Theraclion S.A.
ALTHE.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | €1 | €2 | €1 | €1 |
| % Growth | -54.5% | 47.5% | -16.6% | – |
| Cost of Goods Sold | €8 | €3 | €4 | €6 |
| Gross Profit | -€7 | -€1 | -€3 | -€5 |
| % Margin | -865.4% | -59.3% | -246.9% | -306.5% |
| R&D Expenses | €0 | €0 | €4 | €4 |
| G&A Expenses | €0 | €0 | €0 | €0 |
| SG&A Expenses | €1 | €0 | €0 | €0 |
| Sales & Mktg Exp. | €0 | €0 | €0 | €0 |
| Other Operating Expenses | -€1 | €2 | -€1 | -€4 |
| Operating Expenses | -€0 | €2 | €3 | €0 |
| Operating Income | -€7 | -€3 | -€6 | -€5 |
| % Margin | -838.6% | -173.1% | -510.5% | -319.9% |
| Other Income/Exp. Net | €0 | -€2 | €0 | €0 |
| Pre-Tax Income | -€7 | -€5 | -€6 | -€5 |
| Tax Expense | -€1 | -€1 | -€1 | -€1 |
| Net Income | -€6 | -€4 | -€5 | -€4 |
| % Margin | -693.6% | -201.7% | -401.8% | -253.9% |
| EPS | -0.12 | -0.08 | -0.17 | -0.16 |
| % Growth | -49.3% | 52.7% | -6.3% | – |
| EPS Diluted | -0.12 | -0.076 | -0.17 | -0.16 |
| Weighted Avg Shares Out | 46 | 46 | 29 | 23 |
| Weighted Avg Shares Out Dil | 46 | 48 | 29 | 23 |
| Supplemental Information | – | – | – | – |
| Interest Income | €0 | €0 | €0 | €0 |
| Interest Expense | €0 | €0 | €0 | €0 |
| Depreciation & Amortization | -€0 | €0 | €0 | €0 |
| EBITDA | -€7 | -€4 | -€6 | -€4 |
| % Margin | -838.6% | -246.3% | -464.6% | -297.4% |